Navigation Links
Sweet Dreams, Sweet Breath: MedGen Inc. Retains TransMedia Group to Send Media a Wake-Up Call About an All-Natural, Quick New Way to Slumber Land
Date:7/21/2008

PR firm introduces '4 Good Night's Sleep,' an all-natural melatonin strip

that dissolves on the tongue into sweet dreams

BOCA RATON, Fla., July 21 /PRNewswire/ -- TransMedia Group said it was retained to get the word out about a '4 Good Night's Sleep,' all-natural sleep aid for people who can't wait for pills to work, for those who cannot swallow pills, and who want to fall asleep fast and safely. MedGen Inc., the makers of Snorenz, which has over 5 million users, finally introduces this highly-anticipated sleep aid product which has already garnered rave reviews from the test market.

"MedGen Inc. has hired us to introduce '4 Good Night's Sleep," http://www.4goodnightsleep.com , an all-natural melatonin strip that dissolves on your tongue quickly for a great night's sleep," says TransMedia's Senior Vice President, Kim Morgan.

"We choose TransMedia Group to publicize this unique product after seeing the amazing job they've done in promoting innovative health products and helping companies like Rexall Sundown to become the number-one nutritional supplement company in the world," states Paul B. Kravitz, Chairman and CEO of MedGen Inc.

"Our publicity will emphasize how MedGen Inc. saturated the dissolvable strips with pharmaceutical-grade melatonin, which makes it a potent, pleasant and natural way to induce sleep, while it sweetens breath and even provides an anti-oxidant benefit," adds Morgan.

"The all-natural ingredients in '4 Good Night's Sleep' and its unique delivery system will certainly make this product newsworthy at a time when sleepless Americans are worried about their jobs and paying their mortgages in a slowing economy," says TransMedia's CEO Tom Madden.

MedGen Inc. is a fully reporting public company listed on the NASDAQ OTCBB Exchange. Incorporated in 1996, MedGen's products seek approval from both health professionals and the general
'/>"/>

SOURCE TransMedia Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New Health Corp. Announces the Addition of Hannaford Bros., Kash N Karry and Sweet Bay Supermarkets to its Retail Outlets
2. Serta Brings Sweet Dreams and a Special Delivery to Deserving Women
3. Patients may have sweet and effective way to prepare for upper GI endoscopy: an anesthetic lollipop
4. Smoking Dulls Taste for Sweets
5. Chocolate Has Sweet Effect on Blood Flow
6. Looking For Some Sweet and Healthy Stocking Stuffers?
7. Sunsweet Introduces PlumSmart Light(R)
8. Artificial sweeteners linked to weight gain
9. New Web Site Lets You Test Your Sweet-Smarts Just in Time for Valentines Day and Easter
10. Photo: Sweet Dreams From Turkey
11. A ton of bitter melon produces sweet results for diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 16, 2014 (HealthDay News) -- Almost all the ... in veins are equally safe and effective, new ... effectiveness of treatments for such blood clots as ... in a lung), Canadian researchers analyzed outcomes associated ... heparin (LMWH) and fondaparinux in combination with vitamin ...
(Date:9/16/2014)... Dennis Thompson HealthDay ... -- A combination drug therapy aimed at opening the ... treatment for older adults with chronic obstructive pulmonary disease ... COPD patients who received a combination of ... to die or require hospitalization because of their breathing ...
(Date:9/16/2014)... York (PRWEB) September 16, 2014 ... filed against C.R. Bard, Inc. continue to move ... U.S. District Court, Southern District of West Virginia, ... dated September 15, 2014, the Court has determined ... to the proceeding. The Order indicates that the ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Novatus, a ... a new office in London, UK, and appointed Jim ... in Europe, the expansion will allow Novatus to target ... its European customers. , “Novatus is ... and London is an ideal location to establish our ...
(Date:9/16/2014)... The child molestation victim lawyers at Estey ... who, according to case documents, were allegedly sexually abused ... San Diego. The victims were allegedly in elementary school ... of the defendant in the case remains confidential, per ... noted that no criminal charges were filed against the ...
Breaking Medicine News(10 mins):Health News: Most Treatments for Blood Clots Appear Safe, Effective 2Health News:Combo Therapy Best for COPD: Study 2Health News:Combo Therapy Best for COPD: Study 3Health News:Vaginal Mesh Lawsuit News: Discovery Conferences Scheduled for Federal Transvaginal Mesh Lawsuits Filed Against C.R. Bard, Bernstein Liebhard LLP Reports 2Health News:Vaginal Mesh Lawsuit News: Discovery Conferences Scheduled for Federal Transvaginal Mesh Lawsuits Filed Against C.R. Bard, Bernstein Liebhard LLP Reports 3Health News:Vaginal Mesh Lawsuit News: Discovery Conferences Scheduled for Federal Transvaginal Mesh Lawsuits Filed Against C.R. Bard, Bernstein Liebhard LLP Reports 4Health News:Novatus Expands European Operations with a New Office in London 2Health News:ESTEY BOMBERGER Announces $3 Million Settlement for Sexual Abuse at San Diego Private School 2
... , SEATTLE, Aug. 24 Cell Therapeutics, Inc. (CTI) ... Drug Administration (FDA) has accepted and has filed for review the ... or refractory aggressive non-Hodgkin,s lymphoma (NHL). A Prescription Drug User Fee ... review of the pixantrone NDA by September 4th 2009. ...
... at the time of diagnosis do not live as long ... conclusion of a new study to be published in the ... journal of the American Cancer Society. The authors of the ... marital separation may compromise an individual,s immune system and lead ...
... factor for active tuberculosis (TB) disease, according to a new ... analyzed data from nearly 17,000 individuals in Taiwan as part ... past studies have reported increased mortality among TB patients who ... effect of smoking on active TB incidence using a longitudinal ...
... A new technique may help clinicians hone in on a ... cause. The study, led by principal investigator Y.C. ... the American Thoracic Society,s American Journal of Respiratory and ... of fluid in the pleural cavity, can be maddeningly difficult ...
... Over one-hundred business ... , ... -- Rooted in Newtonian and quantum science, ancient spiritual and healing traditions, and clinical studies, ... book ColorAlchemy , by Jami Lin teaches people how to harness a daily color ...
... diagnosis of Idiopathic Pulmonary Fibrosis is not much better ... the survival rate is less than three years. ... that targeting of a novel gene utilizing genetic and ... mice and will be developed for future testing in ...
Cached Medicine News:Health News:FDA Accepts to File Cell Therapeutics' New Drug Application for Pixantrone 2Health News:FDA Accepts to File Cell Therapeutics' New Drug Application for Pixantrone 3Health News:Cancer patients who are separated when diagnosed have worse survival rates 2Health News:Smoking increases risk of developing active TB 2Health News:Smoking increases risk of developing active TB 3Health News:New technique can help diagnose mesothelioma 2Health News:Business Association in Denver Invites Award-winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using the Color Red 2Health News:Business Association in Denver Invites Award-winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using the Color Red 3Health News:Business Association in Denver Invites Award-winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using the Color Red 4Health News:U-M researchers discover therapeutic target that could help patients with pulmonary fibrosis 2
(Date:9/16/2014)... 2014 The National Association of Managed ... released the NAMCP Medical Technologies Dossier Template © ... © , which provide medical directors and manufacturers ... devices or diagnostics that accounts for evidence-based development ... technology types (instead of having to attempt to ...
(Date:9/16/2014)... , Sept. 16, 2014 The Lupus ... LLY ) today released results from UNVEIL: ... sheds light on the lupus journey and the challenges ... for lupus caregivers. The UNVEIL study, which involved over ... devastating impact lupus has on all aspects of life ...
(Date:9/16/2014)... Alberta , Sept. 16, 2014  Wearable ... billion industry in less than two years, producing ... the way. A huge opportunity exists for leveraging ... Vivametrica ( http://vivametrica.com/our-video/ ) introduced a first-of-its-kind wearable ... based on years of clinical research linking activity ...
Breaking Medicine Technology:NAMCP Medical Directors Institute releases NAMCP Medical Technologies and Diagnostics Dossier Templates to provide model approach for medical devices or diagnostics 2"UNVEIL" Survey Reveals a Life Interrupted by Lupus 2"UNVEIL" Survey Reveals a Life Interrupted by Lupus 3"UNVEIL" Survey Reveals a Life Interrupted by Lupus 4"UNVEIL" Survey Reveals a Life Interrupted by Lupus 5Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 2Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 3
... Mass., Oct. 26 DUSA Pharmaceuticals, Inc.® (Nasdaq: ... dermatology announced today that it has been named to ... consecutive year, Deloitte recognized DUSA as one of the ... and clean technology companies in North America.  Rankings are ...
... Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop... -- INGELHEIM, Germany and ROCKVILLE, Md., Oct. 26 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
Cached Medicine Technology:DUSA Pharmaceuticals Named to Deloitte's 2010 Technology Fast 500 List of Fastest Growing Companies in North America 2Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics 2Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics 3Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics 4Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics 5Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics 6Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics 7Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics 8Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics 9Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics 10
... System is a point-of-care system designed for ... referred to as Platelet Rich Plasma - ... a small sample of blood. The Symphony ... factors, which are found in the platelets. ...
... Dual Imaging Color Module Leica combines precision microscopy ... important and necessary patient data can be displayed ... optical platform on the Leica OH3, OHS1, MS3 ... highest brightness, contrast >300:1, true color and resolution ...
... Headlight mounted micro video camera has ... pictures in areas otherwise invisible to all ... capabilities. The system may be used for ... eliminating crowding of the sterile area and ...
... DXC-S500 consists of 2-piece body, one is CHU ... and built-in Peltier cooling devices, the other is ... monitor. CCU incorporates IEEE1394 interface for direct connection ... card slot for storing images into memory stick ...
Medicine Products: